Cytokinetics (CYTK) Misses Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $76.10 +0.30%
Financial Fact:
Operating loss: 32.49M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Operating loss: 32.49M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.67), $0.02 worse than the analyst estimate of ($1.65). Revenue for the quarter came in at $19.35 million versus the consensus estimate of $8.59 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- AXIL Brands (AXIL) Tops Q4 EPS by 4c
- Trump highlights ibogaine development push, Psyence BioMed responds
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
